巴雷特食管肿瘤检出率及其对漏诊异型增生影响:基于大型人群数据库的结果
该研究分析1991至2019年明尼苏达州东南部11县人群队列中1066例巴雷特食管患者,首次监测内镜的肿瘤检出率为4.9%(95%CI 3.8-6.4),漏诊异型增生率为13%,均低于既往报道;肿瘤检出率或可作为巴雷特食管监测的质量指标,但需在其他队列中验证。
要点
- 巴雷特食管首次监测内镜的肿瘤检出率为4.9%,其中高级别异型增生3.1%、食管腺癌1.8%。
- 肿瘤检出率与漏诊异型增生率较低(13%),均低于既往转诊中心报道。
- 高龄、男性、吸烟、巴雷特食管长度增加及由胃肠病学家操作与更高肿瘤检出率相关。
核心结论
- 在1066例巴雷特食管人群队列中,肿瘤检出率和漏诊异型增生率均低于既往报道。
- 肿瘤检出率若在其他队列中得到验证,或可作为巴雷特食管监测的质量指标。
研究设计与样本
- 分析罗切斯特流行病学项目关联病历系统中1991至2019年明尼苏达州东南部11县的人群队列,共1066例经内镜和组织学报告复核确认的巴雷特食管患者。
- 报告异型增生的活检由胃肠病理专家复核确认。
- 肿瘤检出率定义为首次监测内镜活检组织学分析检出高级别异型增生或食管腺癌的比率。
- 首次内镜无高级别异型增生或食管腺癌的患者(n=391)在12个月内接受重复内镜,重复内镜检出的高级别异型增生或食管腺癌视为首次内镜漏诊。
- 采用单因素和多因素逻辑回归模型识别与肿瘤检出率和漏诊异型增生相关的因素。
主要发现
- 肿瘤检出率为4.9%(95%CI 3.8-6.4),3.1%的患者有高级别异型增生,1.8%有食管腺癌,10.6%有低级别异型增生。
- 与更高肿瘤检出率相关的因素包括年龄较大、男性、吸烟、巴雷特食管长度增加及由胃肠病学家行监测内镜。
- 该肿瘤检出率与显著较低的漏诊异型增生率(13%)相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: It is a challenge to detect dysplasia in Barrett's esophagus (BE) and esophageal adenocarcinomas (EACs) are missed in 25%-33% of cases. The neoplasia detection rate (NDR), defined as the rate of high-grade dysplasia (HGD) or EAC detection during initial surveillance endoscopy, has been proposed as a quality metric for endoscopic evaluation of patients with BE. However, current estimates are from referral center cohorts, which might overestimate NDR. Effects on rates of missed dysplasia are also unknown. We analyzed data from a large cohort of patients with BE to estimate the NDR and factors associated with it, and assess the effects of the NDR on the rate of missed dysplasia. METHODS: We analyzed data from 1066 patients in the Rochester Epidemiology Project-linked medical record system, a population-based cohort of patients with BE (confirmed by review of the endoscopic and histologic reports) from 11 southeastern Minnesota counties from 1991 through 2019. Biopsies reported to contain dysplasia were confirmed by expert gastrointestinal pathologists. The NDR was calculated as the rate of HGD or EAC detected by histologic analyses of biopsies collected during the first surveillance endoscopy. Patients without HGD or EAC at their initial endoscopy (n = 391) underwent repeat endoscopy within 12 months; HGD or EAC detected at the repeat endoscopy were considered to be missed on index endoscopy. Factors associated with NDR and missed dysplasia were identified using univariate and multivariate logistic regression models. RESULTS: The NDR was 4.9% (95% CI, 3.8-6.4); 3.1% of patients had HGD, 1.8% had EAC, and 10.6% had low-grade dysplasia. Factors associated with higher rates of detection of neoplasia included older age, male sex, smoking, increasing length of BE, and surveillance endoscopies by gastroenterologists. This NDR was associated with a substantially lower rate of missed dysplasia (13%). CONCLUSIONS: In an analysis of 1066 patients with BE in a population-based cohort, we found a lower NDR and lower rate of missed dysplasia than previously reported. NDR may have value as a quality metric in BE surveillance if validated in other cohorts.
引用
- Dhaliwal L, Codipilly DC, Gandhi P, et al. Neoplasia Detection Rate in Barrett's Esophagus and Its Impact on Missed Dysplasia: Results from a Large Population-Based Database. Clin Gastroenterol Hepatol. 2020. PMID: 32707339. doi:10.1016/j.cgh.2020.07.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。